NOBEL BIOCARE DANMARK A/S: Financial statements 2021
CVR: 28293364
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 4,267,743 and a net result of DKK 267,699 compared with DKK -793,925 the year before. That is a decrease of 10.8% compared with the year before. Equity in the 2021 report amounted to DKK 858,111. The solvency ratio was 1.4%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 4,267,743
- Profit/Loss
- DKK 267,699
- Equity
- DKK 858,111
- Total Assets
- DKK 62,220,480
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 4.3M | 268K | 858K | 3 |
| 2020 | - | 4.8M | -794K | -1.4M | 5 |
| 2019 | - | 4M | -5.5M | -616K | 4 |
| 2018 | - | 3.3M | 420K | 4.9M | 3 |
| 2017 | - | 3.8M | 580K | 4.4M | 4 |
Official annual report
Find more companies like NOBEL BIOCARE DANMARK A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
NOBEL BIOCARE DANMARK A/S has published its annual report for 2020. Gross profit came to DKK 4,787,016, and the net result was DKK -793,925.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.